查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1467762

2024-2032 年亨廷頓舞蹈症治療市場報告（按類型、藥物類型、年齡、配銷通路、最終用戶和地區）

Huntington's Disease Treatment Market Report by Type, Drug Type, Age, Distribution Channel, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2023年全球IMARC Group舞蹈症治療市場規模達4.911億美元。亨廷頓舞蹈症發病率的上升、對該疾病治療的先進藥物的需求不斷增加以及創新治療方法的最新發展是推動市場的一些關鍵因素。

亨廷頓舞蹈症是指一種致命的神經退化性疾病，會導致大腦中的神經細胞進行性破壞。其症狀包括各種運動、精神和認知障礙，如不自主抽搐、肌肉問題、組織和注意力困難、缺乏意識、失眠和社交退縮。亨廷頓氏症的治療涉及多種藥物的應用，例如抗精神病藥、抗憂鬱藥、抗巴金森藥和情緒穩定藥。治療過程還包括各種療法，例如語言療法、職業療法、物理療法和心理療法。亨廷頓舞蹈症治療有助於最大程度地減少運動和精神障礙的症狀，幫助患者在更短的時間內適應新的能力，並制定應對策略。它還有助於改善日常任務、言語、保持姿勢和平衡以及提高生活品質。

亨廷頓舞蹈症治療市場趨勢：

全球亨廷頓舞蹈症發生率的上升是推動市場成長的主要因素之一。亨廷頓舞蹈症治療廣泛用於抑制不自主的抽搐和扭動運動，治療舞蹈症，減少暴力爆發和躁動，增強力量、靈活性、平衡性和協調性，從而改善生活品質並增強患者的能力執行日常任務，例如吃飯、通訊和行走。此外，對控制與亨廷頓舞蹈症相關的運動、認知和精神症狀的先進藥物的需求不斷增加，也推動了市場的成長。與此一致的是，由於對該疾病及其根本原因的了解加深，新的疾病緩解藥物的快速開發正在成為另一個生長誘導因素。此外，最近開發的創新治療方法透過降低突變亨廷頓蛋白 (mTT) 的產生水平來阻止亨廷頓氏症的生長，對市場產生了積極影響。除此之外，使用反義寡核苷酸（ASO）靶向亨廷頓蛋白（HTT）信使核糖核酸（mRNA）及其整個中樞神經系統（CNS）蛋白質的反義技術的引入正在推動市場成長。此外，多個政府加大力度促進新藥開發也有利於市場成長。其他因素，包括大眾對亨廷頓病的認知不斷提高、醫療保健行業的顯著成長、研發（R&D）活動投資的增加、老年人口的增加以及對標籤外藥物的需求不斷增加，預計將推動市場的發展生長。

本報告回答的關鍵問題

  • 2023年全球亨廷頓舞蹈症治療市場規模有多大？
  • 2024-2032年全球亨廷頓舞蹈症治療市場的預期成長率是多少？
  • 推動全球亨丁頓舞蹈症治療市場的關鍵因素是什麼？
  • COVID-19 對全球亨廷頓舞蹈症治療市場有何影響？
  • 全球亨廷頓舞蹈症治療市場按類型分類是怎樣的？
  • 根據藥物類型，全球亨廷頓舞蹈症治療市場的詳細情形如何？
  • 全球亨廷頓舞蹈症治療市場以年齡分類是怎樣的？
  • 基於配銷通路的全球亨廷頓舞蹈症治療市場的詳細情形如何？
  • 全球亨廷頓舞蹈症治療市場的關鍵區域有哪些？
  • 全球亨廷頓舞蹈症治療市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球亨廷頓舞蹈症治療市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 症狀治療
    • 市場走向
    • 市場預測
  • 疾病緩解療法
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依藥物類型

  • 批准的藥物
    • 市場走向
    • 關鍵環節
      • 丁苯那嗪
      • 丁苯那嗪
    • 市場預測
  • 標籤外藥物
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依年齡

  • 50歲以下
    • 市場走向
    • 市場預測
  • 50歲以上
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按配銷通路

  • 藥局和零售藥局
    • 市場走向
    • 市場預測
  • 醫院藥房
    • 市場走向
    • 市場預測
  • 網路藥局
    • 市場走向
    • 市場預測

第 10 章：市場區隔：依最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 居家護理
    • 市場走向
    • 市場預測
  • 專科診所
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 12 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：價格分析

第16章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AOP Health
    • Apotex Inc.
    • Dr. Reddy's Laboratories Ltd.
    • H. Lundbeck A/S
    • Hikma Pharmaceuticals PLC
    • Lupin Limited
    • Prilenia Therapeutics
    • Sun Pharmaceutical Industries Limited
    • Teva Pharmaceutical Industries Ltd.
    • Vaccinex Inc.
Product Code: SR112024A6883

The global Huntington's disease treatment market size reached US$ 491.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,248.1 Million by 2032, exhibiting a growth rate (CAGR) of 17.9% during 2024-2032. The rising incidences of Huntington's disease, the increasing demand for advanced drugs for the disease treatment, and recent development of innovative therapeutic approaches represent some of the key factors driving the market.

Huntington's disease refers to a fatal neurodegenerative disorder that causes the progressive breakdown of nerve cells in the brain. Its symptoms include various movement, psychiatric, and cognitive impairments, such as involuntary jerking, muscle problems, difficulty in organizing and focusing, lack of awareness, insomnia, and social withdrawal. Huntington's disease treatment involves the application of various drugs, such as antipsychotics, antidepressants, antiparkinsonians, and mood-stabilizing drugs. The treatment process also includes various therapies, such as speech, occupational, physical, and psychotherapy. Huntington's disease treatment helps in minimizing the symptoms of movement and psychiatric disorders, assists patients in adapting to new abilities in a shorter time, and develops coping strategies. It also aids in improving everyday tasks, speech, maintaining posture and balance, and enhancing the quality of life.

Huntington's Disease Treatment Market Trends:

The rising incidence of Huntington's disease across the globe is one of the primary factors driving the market growth. Huntington's disease treatment is widely used to suppress involuntary jerking and writhing movement, treat chorea, reduce violent outbursts and agitation, and enhance strength, flexibility, balance, and coordination, which, in turn, improves the quality of life and enhances the patient's ability to carry out daily routine tasks, such as eating, communications, and walking. Furthermore, the increasing demand for advanced drugs to control the motor, cognitive, and psychiatric symptoms associated with Huntington's disease is providing an impetus to the market growth. In line with this, the rapid development of new disease-modifying drugs owing to the improved understanding of the disease, and its underlying causes are acting as another growth-inducing factor. Additionally, the recent development of the innovative therapeutic approach that deters the growth of Huntington's disease by reducing mutant huntingtin (mTT) production levels is positively influencing the market. Apart from this, the introduction of antisense technology that uses antisense oligonucleotides (ASOs) to target huntingtin (HTT) messenger ribonucleic acid (mRNA) and its protein throughout the central nervous system (CNS) is propelling the market growth. Moreover, increasing initiatives by several governments to promote the development of novel drugs are favoring the market growth. Other factors, including rising awareness among the masses regarding Huntington's disease, significant growth in the healthcare industry, increasing investment in research and development (R&D) activities, rising geriatric population, and escalating demand for off-label medications, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global Huntington's disease treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, drug type, age, distribution channel, and end user.

Type Insights:

Symptomatic Treatment

Disease-modifying Therapies

The report has also provided a detailed breakup and analysis of the Huntington's disease treatment market based on the type. This includes symptomatic treatment and disease-modifying therapies. According to the report, symptomatic treatment represented the largest segment.

Drug Type Insights:

Approved Drugs

Tetrabenazine

Deutetrabenazine

Off-label Drugs

A detailed breakup and analysis of the Huntington's disease treatment market based on the drug type has been provided in the report. This includes approved drugs (tetrabenazine and deutetrabenazine) and off-label drugs. According to the report, approved drugs accounted for the largest market share.

Age Insights:

Below 50 Years

Above 50 Years

A detailed breakup and analysis of the Huntington's disease treatment market based on the age has been provided in the report. This includes below 50 years and above 50 years. According to the report, below 50 years accounted for the largest market share.

Distribution Channel Insights:

Drug Stores and Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

A detailed breakup and analysis of the Huntington's disease treatment market based on the distribution channel has been provided in the report. This includes drug store and retail, hospital, and online pharmacies. According to the report, drug store and retail pharmacies accounted for the largest market share.

End User Insights:

Hospitals

Homecare

Specialty Clinics

Others

A detailed breakup and analysis of the Huntington's disease treatment market based on the end users has been provided in the report. This includes hospitals, homecare, specialty clinics, and others.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for Huntington's disease treatment. Some of the factors driving the North America Huntington's disease treatment market includes significant technological advancements, the rapid development of healthcare infrastructure, and the rising number of individuals suffering from Huntington's disease.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global Huntington's disease treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AOP Health, Apotex Inc., Dr. Reddy's Laboratories Ltd., H. Lundbeck A/S, Hikma Pharmaceuticals PLC, Lupin Limited, Prilenia Therapeutics, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Vaccinex Inc. etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global Huntington's disease treatment market in 2023?
  • 2. What is the expected growth rate of the global Huntington's disease treatment market during 2024-2032?
  • 3. What are the key factors driving the global Huntington's disease treatment market?
  • 4. What has been the impact of COVID-19 on the global Huntington's disease treatment market?
  • 5. What is the breakup of the global Huntington's disease treatment market based on the type?
  • 6. What is the breakup of the global Huntington's disease treatment market based on the drug type?
  • 7. What is the breakup of the global Huntington's disease treatment market based on the age?
  • 8. What is the breakup of the global Huntington's disease treatment market based on the distribution channel?
  • 9. What are the key regions in the global Huntington's disease treatment market?
  • 10. Who are the key players/companies in the global Huntington's disease treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Huntington's Disease Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Symptomatic Treatment
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Disease-modifying Therapies
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Approved Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Tetrabenazine
      • 7.1.2.2 Deutetrabenazine
    • 7.1.3 Market Forecast
  • 7.2 Off-label Drugs
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Age

  • 8.1 Below 50 Years
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Above 50 Years
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Drug Store and Retail Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospital Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Homecare
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Specialty Clinics
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

  • 12.1 Overview
  • 12.2 Drivers
  • 12.3 Restraints
  • 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 AOP Health
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Apotex Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 SWOT Analysis
    • 16.3.3 Dr. Reddy's Laboratories Ltd.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 H. Lundbeck A/S
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Hikma Pharmaceuticals PLC
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Lupin Limited
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Prilenia Therapeutics
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Sun Pharmaceutical Industries Limited
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Teva Pharmaceutical Industries Ltd.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Vaccinex Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Huntington's Disease Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Huntington's Disease Treatment Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Huntington's Disease Treatment Market: Breakup by Drug Type (in %), 2023
  • Figure 6: Global: Huntington's Disease Treatment Market: Breakup by Age (in %), 2023
  • Figure 7: Global: Huntington's Disease Treatment Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Huntington's Disease Treatment Market: Breakup by End User (in %), 2023
  • Figure 9: Global: Huntington's Disease Treatment Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Huntington's Disease Treatment (Symptomatic Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Huntington's Disease Treatment (Symptomatic Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Huntington's Disease Treatment (Disease-modifying Therapies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Huntington's Disease Treatment (Disease-modifying Therapies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Huntington's Disease Treatment (Approved Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Huntington's Disease Treatment (Approved Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Huntington's Disease Treatment (Off-label Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Huntington's Disease Treatment (Off-label Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Huntington's Disease Treatment (Below 50 Years) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Huntington's Disease Treatment (Below 50 Years) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Huntington's Disease Treatment (Above 50 Years) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Huntington's Disease Treatment (Above 50 Years) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Huntington's Disease Treatment (Drug Store and Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Huntington's Disease Treatment (Drug Store and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Huntington's Disease Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Huntington's Disease Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Huntington's Disease Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Huntington's Disease Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Huntington's Disease Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Huntington's Disease Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Huntington's Disease Treatment (Homecare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Huntington's Disease Treatment (Homecare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Huntington's Disease Treatment (Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Huntington's Disease Treatment (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Huntington's Disease Treatment (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Huntington's Disease Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: United States: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: United States: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Canada: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Canada: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Asia-Pacific: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Asia-Pacific: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: China: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: China: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Japan: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Japan: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: India: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: India: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: South Korea: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: South Korea: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Australia: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Australia: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Indonesia: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Indonesia: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Others: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Others: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Europe: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Europe: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Germany: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Germany: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: France: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: France: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United Kingdom: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United Kingdom: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Italy: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Italy: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Spain: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Spain: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Russia: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Russia: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Middle East and Africa: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Middle East and Africa: Huntington's Disease Treatment Market: Breakup by Country (in %), 2023
  • Figure 84: Middle East and Africa: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Global: Huntington's Disease Treatment Industry: Drivers, Restraints, and Opportunities
  • Figure 86: Global: Huntington's Disease Treatment Industry: Value Chain Analysis
  • Figure 87: Global: Huntington's Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Huntington's Disease Treatment Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Huntington's Disease Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Huntington's Disease Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 4: Global: Huntington's Disease Treatment Market Forecast: Breakup by Age (in Million US$), 2024-2032
  • Table 5: Global: Huntington's Disease Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Huntington's Disease Treatment Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: Huntington's Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Huntington's Disease Treatment Market: Competitive Structure
  • Table 9: Global: Huntington's Disease Treatment Market: Key Players